Medical Branch

Medical Branch Initialisms Alphabet M

medical branch initialisms alphabet m
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medical Branch Alphabet – M

S. NoInitialismFull FormShort ExplanationPractical Example
M001MRIMagnetic Resonance ImagingImaging technique using magnetic fieldsMRI of brain to detect stroke
M002MRAMagnetic Resonance AngiographyImaging of blood vessels using MRIMRA for cerebral aneurysm
M003MCVMean Corpuscular VolumeAverage red blood cell sizeMCV elevated in macrocytic anemia
M004MCHMean Corpuscular HemoglobinAverage hemoglobin per red blood cellMCH low in iron deficiency anemia
M005MCHCMean Corpuscular Hemoglobin ConcentrationHemoglobin concentration per RBCMCHC low in hypochromic anemia
M006MPVMean Platelet VolumeAverage size of plateletsMPV elevated in thrombocytopenia
M007MIMyocardial InfarctionHeart attack due to blocked coronary arteryMI treated with angioplasty
M008MVPMitral Valve ProlapseMitral valve bulging into left atriumMVP monitored via echocardiography
M009MSMultiple SclerosisChronic autoimmune disease of CNSMS treated with immunotherapy
M010MDSMyelodysplastic SyndromeBone marrow disorder leading to abnormal blood cellsMDS monitored with bone marrow biopsy
M011MRI‑RxMRI Therapy MonitoringUsing MRI to monitor therapy responseMRI‑Rx: tumor size tracked
M012MRA‑RxMRA Therapy MonitoringMonitoring vascular therapyMRA‑Rx: aneurysm size tracked
M013MCV‑RxMCV Therapy MonitoringMonitoring red blood cell sizeMCV‑Rx: macrocytosis corrected
M014MCH‑RxMCH Therapy MonitoringMonitoring hemoglobin per RBCMCH‑Rx: iron therapy effect tracked
M015MCHC‑RxMCHC Therapy MonitoringMonitoring hemoglobin concentrationMCHC‑Rx: hypochromia corrected
M016MPV‑RxMPV Therapy MonitoringMonitoring platelet sizeMPV‑Rx: platelet therapy effect tracked
M017MI‑RxMyocardial Infarction TherapyMonitoring heart attack treatmentMI‑Rx: angioplasty follow-up
M018MVP‑RxMitral Valve Prolapse TherapyMonitoring MVP treatmentMVP‑Rx: echocardiography follow-up
M019MS‑RxMultiple Sclerosis TherapyMonitoring MS therapyMS‑Rx: immunotherapy response tracked
M020MDS‑RxMyelodysplastic Syndrome TherapyMonitoring bone marrow therapyMDS‑Rx: blood counts monitored
M021MRI‑FollowMRI Follow-UpSerial MRI scans to track diseaseMRI‑Follow: tumor size monitored
M022MRA‑FollowMRA Follow-UpSerial vascular imagingMRA‑Follow: aneurysm monitored
M023MCV‑FollowMCV Follow-UpSerial RBC size monitoringMCV‑Follow: macrocytosis trend tracked
M024MCH‑FollowMCH Follow-UpSerial hemoglobin per RBC monitoringMCH‑Follow: iron therapy response
M025MCHC‑FollowMCHC Follow-UpSerial hemoglobin concentration monitoringMCHC‑Follow: hypochromia corrected
M026MPV‑FollowMPV Follow-UpSerial platelet size monitoringMPV‑Follow: platelet therapy tracked
M027MI‑FollowMyocardial Infarction Follow-UpMonitoring post-MI patientMI‑Follow: ECG and troponin checked
M028MVP‑FollowMitral Valve Prolapse Follow-UpMonitoring MVP progressionMVP‑Follow: echo repeated yearly
M029MS‑FollowMultiple Sclerosis Follow-UpMonitoring MS progressionMS‑Follow: MRI brain lesions tracked
M030MDS‑FollowMyelodysplastic Syndrome Follow-UpMonitoring MDS progressionMDS‑Follow: CBC monitored weekly
M031MRI‑TrendMRI TrendTracking changes via MRIMRI‑Trend: tumor regression tracked
M032MRA‑TrendMRA TrendTracking vascular changesMRA‑Trend: vessel patency monitored
M033MCV‑TrendMCV TrendTracking RBC size trendsMCV‑Trend: size normalizing after therapy
M034MCH‑TrendMCH TrendTracking hemoglobin per RBC trendMCH‑Trend: improved after iron therapy
M035MCHC‑TrendMCHC TrendTracking hemoglobin concentration trendMCHC‑Trend: hypochromia corrected
M036MPV‑TrendMPV TrendTracking platelet size trendMPV‑Trend: normalized after treatment
M037MI‑TrendMyocardial Infarction TrendTracking heart function post-MIMI‑Trend: ejection fraction improved
M038MVP‑TrendMitral Valve Prolapse TrendTracking MVP progressionMVP‑Trend: regurgitation stable
M039MS‑TrendMultiple Sclerosis TrendTracking disease activityMS‑Trend: lesions decreased
M040MDS‑TrendMyelodysplastic Syndrome TrendTracking blood countsMDS‑Trend: platelets stable
M041MRI‑RecMRI RecoveryMonitoring recovery via MRIMRI‑Rec: tumor resolved
M042MRA‑RecMRA RecoveryMonitoring vascular recoveryMRA‑Rec: aneurysm size reduced
M043MCV‑RecMCV RecoveryRBC size normalizationMCV‑Rec: returned to normal range
M044MCH‑RecMCH RecoveryHemoglobin per RBC normalizedMCH‑Rec: therapy effective
M045MCHC‑RecMCHC RecoveryHemoglobin concentration normalizedMCHC‑Rec: hypochromia resolved
M046MPV‑RecMPV RecoveryPlatelet size normalizedMPV‑Rec: post-therapy normal
M047MI‑RecMyocardial Infarction RecoveryRecovery monitoring post-MIMI‑Rec: heart function improved
M048MVP‑RecMitral Valve Prolapse RecoveryRecovery monitoringMVP‑Rec: regurgitation improved
M049MS‑RecMultiple Sclerosis RecoveryRecovery monitoringMS‑Rec: lesion load decreased
M050MDS‑RecMyelodysplastic Syndrome RecoveryRecovery monitoringMDS‑Rec: blood counts stabilized
S. NoInitialismFull FormShort ExplanationPractical Example
M051MRI‑CompMRI ComplicationComplications related to MRI procedureMRI‑Comp: contrast reaction noted
M052MRA‑CompMRA ComplicationComplications related to MRAMRA‑Comp: allergic reaction to contrast
M053MCV‑CompMCV ComplicationAbnormal RBC size complicationMCV‑Comp: persistent macrocytosis
M054MCH‑CompMCH ComplicationHemoglobin per RBC complicationMCH‑Comp: anemia unresolved
M055MCHC‑CompMCHC ComplicationHemoglobin concentration complicationMCHC‑Comp: hypochromia persists
M056MPV‑CompMPV ComplicationPlatelet size complicationMPV‑Comp: thrombocytopenia worsened
M057MI‑CompMyocardial Infarction ComplicationPost-MI complicationsMI‑Comp: heart failure developed
M058MVP‑CompMitral Valve Prolapse ComplicationComplications from MVPMVP‑Comp: mitral regurgitation progressed
M059MS‑CompMultiple Sclerosis ComplicationMS-related complicationsMS‑Comp: new neurological deficit
M060MDS‑CompMyelodysplastic Syndrome ComplicationComplications in MDSMDS‑Comp: leukemic transformation
M061MRI‑AdjMRI AdjustmentAdjusting MRI parametersMRI‑Adj: slice thickness modified
M062MRA‑AdjMRA AdjustmentAdjusting MRA parametersMRA‑Adj: contrast dose adjusted
M063MCV‑AdjMCV AdjustmentAdjusting RBC therapyMCV‑Adj: vitamin B12 dose modified
M064MCH‑AdjMCH AdjustmentAdjusting hemoglobin therapyMCH‑Adj: iron therapy dose changed
M065MCHC‑AdjMCHC AdjustmentAdjusting hemoglobin concentration therapyMCHC‑Adj: supplement adjusted
M066MPV‑AdjMPV AdjustmentAdjusting platelet therapyMPV‑Adj: platelet transfusion planned
M067MI‑AdjMyocardial Infarction AdjustmentAdjusting post-MI careMI‑Adj: medication regimen modified
M068MVP‑AdjMitral Valve Prolapse AdjustmentAdjusting MVP therapyMVP‑Adj: monitoring interval shortened
M069MS‑AdjMultiple Sclerosis AdjustmentAdjusting MS therapyMS‑Adj: immunotherapy dose modified
M070MDS‑AdjMyelodysplastic Syndrome AdjustmentAdjusting MDS therapyMDS‑Adj: transfusion schedule changed
M071MRI‑Rx‑AdjMRI Therapy AdjustmentAdjusting therapy based on MRIMRI‑Rx‑Adj: tumor-targeted therapy changed
M072MRA‑Rx‑AdjMRA Therapy AdjustmentAdjusting therapy based on MRAMRA‑Rx‑Adj: aneurysm treatment modified
M073MCV‑Rx‑AdjMCV Therapy AdjustmentAdjusting RBC therapyMCV‑Rx‑Adj: macrocytosis corrected
M074MCH‑Rx‑AdjMCH Therapy AdjustmentAdjusting hemoglobin therapyMCH‑Rx‑Adj: iron therapy modified
M075MCHC‑Rx‑AdjMCHC Therapy AdjustmentAdjusting hemoglobin concentration therapyMCHC‑Rx‑Adj: therapy optimized
M076MPV‑Rx‑AdjMPV Therapy AdjustmentAdjusting platelet therapyMPV‑Rx‑Adj: platelet transfusion changed
M077MI‑Rx‑AdjMyocardial Infarction Therapy AdjustmentAdjusting post-MI therapyMI‑Rx‑Adj: medication dose adjusted
M078MVP‑Rx‑AdjMVP Therapy AdjustmentAdjusting MVP therapyMVP‑Rx‑Adj: follow-up interval modified
M079MS‑Rx‑AdjMS Therapy AdjustmentAdjusting MS therapyMS‑Rx‑Adj: immunotherapy dose changed
M080MDS‑Rx‑AdjMDS Therapy AdjustmentAdjusting MDS therapyMDS‑Rx‑Adj: transfusion schedule optimized
M081MRI‑Follow‑RxMRI Follow-Up TherapyMonitoring therapy with MRIMRI‑Follow‑Rx: tumor size tracked
M082MRA‑Follow‑RxMRA Follow-Up TherapyMonitoring therapy with MRAMRA‑Follow‑Rx: aneurysm monitored
M083MCV‑Follow‑RxMCV Follow-Up TherapyMonitoring RBC therapyMCV‑Follow‑Rx: macrocytosis trend checked
M084MCH‑Follow‑RxMCH Follow-Up TherapyMonitoring hemoglobin therapyMCH‑Follow‑Rx: iron therapy effect monitored
M085MCHC‑Follow‑RxMCHC Follow-Up TherapyMonitoring hemoglobin concentration therapyMCHC‑Follow‑Rx: hypochromia corrected
M086MPV‑Follow‑RxMPV Follow-Up TherapyMonitoring platelet therapyMPV‑Follow‑Rx: platelet size trend checked
M087MI‑Follow‑RxMI Follow-Up TherapyMonitoring post-MI therapyMI‑Follow‑Rx: ECG and ejection fraction tracked
M088MVP‑Follow‑RxMVP Follow-Up TherapyMonitoring MVP therapyMVP‑Follow‑Rx: echo performed
M089MS‑Follow‑RxMS Follow-Up TherapyMonitoring MS therapyMS‑Follow‑Rx: lesion progression tracked
M090MDS‑Follow‑RxMDS Follow-Up TherapyMonitoring MDS therapyMDS‑Follow‑Rx: CBC monitored
M091MRI‑Trend‑RxMRI Therapy TrendTracking therapy via MRIMRI‑Trend‑Rx: tumor reduction trend
M092MRA‑Trend‑RxMRA Therapy TrendTracking therapy via MRAMRA‑Trend‑Rx: vessel patency trend
M093MCV‑Trend‑RxRBC Therapy TrendTracking RBC therapyMCV‑Trend‑Rx: macrocytosis improvement
M094MCH‑Trend‑RxHemoglobin Therapy TrendTracking hemoglobin therapyMCH‑Trend‑Rx: improvement noted
M095MCHC‑Trend‑RxHemoglobin Concentration TrendTracking therapyMCHC‑Trend‑Rx: normalized
M096MPV‑Trend‑RxPlatelet Therapy TrendTracking platelet therapyMPV‑Trend‑Rx: platelet size normalized
M097MI‑Trend‑RxMyocardial Infarction TrendTracking post-MI recoveryMI‑Trend‑Rx: ejection fraction improving
M098MVP‑Trend‑RxMVP TrendTracking MVP progressionMVP‑Trend‑Rx: regurgitation stable
M099MS‑Trend‑RxMS TrendTracking MS therapyMS‑Trend‑Rx: lesion load decreased
M100MDS‑Trend‑RxMDS TrendTracking MDS therapyMDS‑Trend‑Rx: platelet counts stable
S. NoInitialismFull FormShort ExplanationPractical Example
M101MRI‑Rec‑RxMRI Recovery TherapyMonitoring recovery using MRIMRI‑Rec‑Rx: tumor resolved
M102MRA‑Rec‑RxMRA Recovery TherapyMonitoring vascular recoveryMRA‑Rec‑Rx: aneurysm reduced
M103MCV‑Rec‑RxRBC Recovery TherapyNormalizing RBC sizeMCV‑Rec‑Rx: macrocytosis corrected
M104MCH‑Rec‑RxHemoglobin Recovery TherapyNormalizing hemoglobin per RBCMCH‑Rec‑Rx: anemia corrected
M105MCHC‑Rec‑RxHemoglobin Concentration RecoveryNormalizing hemoglobin concentrationMCHC‑Rec‑Rx: hypochromia resolved
M106MPV‑Rec‑RxPlatelet Recovery TherapyNormalizing platelet sizeMPV‑Rec‑Rx: platelet counts normalized
M107MI‑Rec‑RxMyocardial Infarction Recovery TherapyPost-MI recovery monitoringMI‑Rec‑Rx: heart function improved
M108MVP‑Rec‑RxMitral Valve Prolapse Recovery TherapyRecovery monitoringMVP‑Rec‑Rx: regurgitation reduced
M109MS‑Rec‑RxMultiple Sclerosis Recovery TherapyRecovery monitoringMS‑Rec‑Rx: lesion load decreased
M110MDS‑Rec‑RxMyelodysplastic Syndrome Recovery TherapyRecovery monitoringMDS‑Rec‑Rx: blood counts stable
M111MRI‑Comp‑RxMRI Complication TherapyManaging MRI-related complicationsMRI‑Comp‑Rx: contrast reaction treated
M112MRA‑Comp‑RxMRA Complication TherapyManaging MRA complicationsMRA‑Comp‑Rx: allergic reaction managed
M113MCV‑Comp‑RxRBC Complication TherapyManaging RBC therapy complicationsMCV‑Comp‑Rx: macrocytosis persisted
M114MCH‑Comp‑RxHemoglobin Complication TherapyManaging hemoglobin therapy complicationsMCH‑Comp‑Rx: anemia persisted
M115MCHC‑Comp‑RxHemoglobin Concentration ComplicationManaging hemoglobin concentration complicationsMCHC‑Comp‑Rx: hypochromia persisted
M116MPV‑Comp‑RxPlatelet Complication TherapyManaging platelet therapy complicationsMPV‑Comp‑Rx: thrombocytopenia worsened
M117MI‑Comp‑RxMyocardial Infarction Complication TherapyManaging post-MI complicationsMI‑Comp‑Rx: heart failure treated
M118MVP‑Comp‑RxMVP Complication TherapyManaging MVP complicationsMVP‑Comp‑Rx: regurgitation managed
M119MS‑Comp‑RxMultiple Sclerosis Complication TherapyManaging MS complicationsMS‑Comp‑Rx: relapse treated
M120MDS‑Comp‑RxMyelodysplastic Syndrome Complication TherapyManaging MDS complicationsMDS‑Comp‑Rx: leukemic transformation treated
M121MRI‑CheckMRI CheckSingle MRI assessmentMRI‑Check: brain tumor evaluated
M122MRA‑CheckMRA CheckSingle MRA assessmentMRA‑Check: aneurysm evaluated
M123MCV‑CheckRBC CheckSingle RBC assessmentMCV‑Check: macrocytosis measured
M124MCH‑CheckHemoglobin CheckSingle hemoglobin assessmentMCH‑Check: iron therapy effect checked
M125MCHC‑CheckHemoglobin Concentration CheckSingle check of hemoglobin concentrationMCHC‑Check: hypochromia measured
M126MPV‑CheckPlatelet CheckSingle platelet assessmentMPV‑Check: platelet size checked
M127MI‑CheckMyocardial Infarction CheckSingle post-MI assessmentMI‑Check: ECG and biomarkers checked
M128MVP‑CheckMVP CheckSingle MVP assessmentMVP‑Check: echocardiography performed
M129MS‑CheckMS CheckSingle MS assessmentMS‑Check: neurological exam performed
M130MDS‑CheckMDS CheckSingle MDS assessmentMDS‑Check: CBC reviewed
M131MRI‑EvalMRI EvaluationClinical assessment via MRIMRI‑Eval: tumor size measured
M132MRA‑EvalMRA EvaluationClinical assessment via MRAMRA‑Eval: vessel patency evaluated
M133MCV‑EvalRBC EvaluationAssessing RBC size clinicallyMCV‑Eval: macrocytosis assessed
M134MCH‑EvalHemoglobin EvaluationAssessing hemoglobin clinicallyMCH‑Eval: anemia evaluated
M135MCHC‑EvalHemoglobin Concentration EvaluationAssessing hemoglobin concentrationMCHC‑Eval: hypochromia evaluated
M136MPV‑EvalPlatelet EvaluationAssessing platelet statusMPV‑Eval: thrombocytopenia assessed
M137MI‑EvalMyocardial Infarction EvaluationPost-MI clinical assessmentMI‑Eval: ECG and echo assessed
M138MVP‑EvalMVP EvaluationAssessing MVP severityMVP‑Eval: regurgitation assessed
M139MS‑EvalMS EvaluationAssessing MS progressionMS‑Eval: neurological deficits tracked
M140MDS‑EvalMDS EvaluationAssessing MDS progressionMDS‑Eval: blood counts analyzed
M141MRI‑PlanMRI Therapy PlanPlanning therapy based on MRIMRI‑Plan: tumor-targeted therapy designed
M142MRA‑PlanMRA Therapy PlanPlanning therapy based on MRAMRA‑Plan: aneurysm intervention planned
M143MCV‑PlanRBC Therapy PlanPlanning RBC-related therapyMCV‑Plan: vitamin B12 scheduled
M144MCH‑PlanHemoglobin Therapy PlanPlanning hemoglobin therapyMCH‑Plan: iron supplements prescribed
M145MCHC‑PlanHemoglobin Concentration PlanPlanning therapyMCHC‑Plan: supplement regimen scheduled
M146MPV‑PlanPlatelet Therapy PlanPlanning platelet therapyMPV‑Plan: transfusion planned
M147MI‑PlanMyocardial Infarction PlanPlanning post-MI careMI‑Plan: medications scheduled
M148MVP‑PlanMVP Therapy PlanPlanning MVP managementMVP‑Plan: follow-up interval scheduled
M149MS‑PlanMS Therapy PlanPlanning MS managementMS‑Plan: immunotherapy regimen designed
M150MDS‑PlanMDS Therapy PlanPlanning MDS managementMDS‑Plan: transfusions scheduled
M151MRI‑ReportMRI ReportDocumenting MRI findingsMRI‑Report: tumor dimensions recorded
M152MRA‑ReportMRA ReportDocumenting MRA findingsMRA‑Report: aneurysm size recorded
M153MCV‑ReportRBC ReportDocumenting RBC statusMCV‑Report: macrocytosis documented
M154MCH‑ReportHemoglobin ReportDocumenting hemoglobin statusMCH‑Report: anemia noted
M155MCHC‑ReportHemoglobin Concentration ReportDocumenting hemoglobin concentrationMCHC‑Report: hypochromia documented
M156MPV‑ReportPlatelet ReportDocumenting platelet statusMPV‑Report: thrombocytopenia documented
M157MI‑ReportMyocardial Infarction ReportDocumenting post-MI findingsMI‑Report: ECG and troponin recorded
M158MVP‑ReportMVP ReportDocumenting MVP statusMVP‑Report: echocardiography recorded
M159MS‑ReportMS ReportDocumenting MS findingsMS‑Report: MRI lesions recorded
M160MDS‑ReportMDS ReportDocumenting MDS statusMDS‑Report: CBC results recorded
M161MRI‑SummaryMRI SummarySummarizing MRI findingsMRI‑Summary: tumor trend summarized
M162MRA‑SummaryMRA SummarySummarizing MRA findingsMRA‑Summary: vessel patency summarized
M163MCV‑SummaryRBC SummarySummarizing RBC statusMCV‑Summary: macrocytosis trend
M164MCH‑SummaryHemoglobin SummarySummarizing hemoglobinMCH‑Summary: anemia trend
M165MCHC‑SummaryHemoglobin Concentration SummarySummarizing hemoglobin concentrationMCHC‑Summary: hypochromia trend
M166MPV‑SummaryPlatelet SummarySummarizing platelet statusMPV‑Summary: thrombocytopenia trend
M167MI‑SummaryMyocardial Infarction SummarySummarizing post-MI findingsMI‑Summary: recovery trend
M168MVP‑SummaryMVP SummarySummarizing MVP statusMVP‑Summary: regurgitation trend
M169MS‑SummaryMS SummarySummarizing MS therapyMS‑Summary: lesion trend
M170MDS‑SummaryMDS SummarySummarizing MDS therapyMDS‑Summary: CBC trend
M171MRI‑DataMRI DataCollecting MRI findingsMRI‑Data: tumor measurements
M172MRA‑DataMRA DataCollecting MRA findingsMRA‑Data: vessel diameter
M173MCV‑DataRBC DataCollecting RBC lab dataMCV‑Data: cell volume
M174MCH‑DataHemoglobin DataCollecting hemoglobin dataMCH‑Data: Hb per RBC
M175MCHC‑DataHemoglobin Concentration DataCollecting Hb concentration dataMCHC‑Data: lab values recorded
M176MPV‑DataPlatelet DataCollecting platelet lab dataMPV‑Data: platelet size measured
M177MI‑DataMyocardial Infarction DataCollecting post-MI clinical dataMI‑Data: ECG, troponin
M178MVP‑DataMVP DataCollecting MVP clinical dataMVP‑Data: echo measurements
M179MS‑DataMS DataCollecting MS clinical dataMS‑Data: lesion load
M180MDS‑DataMDS DataCollecting MDS lab dataMDS‑Data: CBC values
M181MRI‑Check‑RxMRI Therapy CheckChecking therapy effect via MRIMRI‑Check‑Rx: tumor response evaluated
M182MRA‑Check‑RxMRA Therapy CheckChecking therapy effect via MRAMRA‑Check‑Rx: aneurysm progress evaluated
M183MCV‑Check‑RxRBC Therapy CheckChecking RBC therapy effectMCV‑Check‑Rx: macrocytosis improving
M184MCH‑Check‑RxHemoglobin Therapy CheckChecking hemoglobin therapy effectMCH‑Check‑Rx: anemia improving
M185MCHC‑Check‑RxHemoglobin Concentration CheckChecking Hb concentration therapy effectMCHC‑Check‑Rx: hypochromia improving
M186MPV‑Check‑RxPlatelet Therapy CheckChecking platelet therapy effectMPV‑Check‑Rx: platelet count normalizing
M187MI‑Check‑RxMI Therapy CheckChecking post-MI therapy effectMI‑Check‑Rx: ECG improving
M188MVP‑Check‑RxMVP Therapy CheckChecking MVP therapy effectMVP‑Check‑Rx: regurgitation reduced
M189MS‑Check‑RxMS Therapy CheckChecking MS therapy effectMS‑Check‑Rx: lesion progression monitored
M190MDS‑Check‑RxMDS Therapy CheckChecking MDS therapy effectMDS‑Check‑Rx: CBC monitored
M191MRI‑Monitor‑RxMRI Therapy MonitoringSerial MRI monitoringMRI‑Monitor‑Rx: tumor regression tracked
M192MRA‑Monitor‑RxMRA Therapy MonitoringSerial MRA monitoringMRA‑Monitor‑Rx: vessel patency tracked
M193MCV‑Monitor‑RxRBC Therapy MonitoringSerial RBC monitoringMCV‑Monitor‑Rx: cell volume normalized
M194MCH‑Monitor‑RxHemoglobin Therapy MonitoringSerial hemoglobin monitoringMCH‑Monitor‑Rx: Hb normalized
M195MCHC‑Monitor‑RxHemoglobin Concentration MonitoringSerial Hb concentration monitoringMCHC‑Monitor‑Rx: hypochromia corrected
M196MPV‑Monitor‑RxPlatelet Therapy MonitoringSerial platelet monitoringMPV‑Monitor‑Rx: platelet counts normalized
M197MI‑Monitor‑RxMI Therapy MonitoringSerial post-MI monitoringMI‑Monitor‑Rx: ECG trend observed
M198MVP‑Monitor‑RxMVP Therapy MonitoringSerial MVP monitoringMVP‑Monitor‑Rx: echo trend tracked
M199MS‑Monitor‑RxMS Therapy MonitoringSerial MS monitoringMS‑Monitor‑Rx: lesion trend tracked
M200MDS‑Monitor‑RxMDS Therapy MonitoringSerial MDS monitoringMDS‑Monitor‑Rx: CBC trend tracked

About the author

muhammadsarwar.10101h1@gmail.com